Article info

Download PDFPDF
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer

Authors

  1. Correspondence to Dr Bruno H Stricker, Department of Epidemiology, Erasmus Medical Center, 3000 CA Rotterdam, Zuid-Holland, Netherlands; b.stricker{at}erasmusmc.nl
View Full Text

Citation

Visser S, Koolen S, van Donk N, et al
Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer

Publication history

  • Received November 1, 2020
  • Revised March 7, 2021
  • Accepted March 11, 2021
  • First published April 15, 2021.
Online issue publication 
October 14, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.